Experimental Study on the Components in Polyvalent ``ghost`` Salmonella Vaccine for Veterinary Use

Simple item page
creativework.publisherHindawi Publishing Corporation410 Park Avenue, 15th Floor, 287 pmbNew YorkNY 10022en
dc.contributor.authorPencheva D.
dc.contributor.authorVelichkova E.
dc.contributor.authorSandarov D.
dc.contributor.authorCardoso A.
dc.contributor.authorMileva M.
dc.contributor.authorGenova-Kalou P.
dc.contributor.authorBryaskova R.
dc.date.accessioned2024-07-10T14:27:03Z
dc.date.accessioned2024-07-10T14:48:29Z
dc.date.available2024-07-10T14:27:03Z
dc.date.available2024-07-10T14:48:29Z
dc.date.issued2015-01-01
dc.description.abstractDevelopment of ``ghost`` Salmonella vaccines, inactivated by using a hybrid nanomaterial based on silver nanoparticles (AgNps) stabilized via polyvinyl alcohol (PVA), is an innovative approach in vaccine production. For this purpose, a series of attempts to establish the components of the polyvalent ``ghost`` Salmonella vaccine and the most suitable methods for its preparation were performed. The following strains S. Enteritidis, S. Newport-Puerto Rico, and S. Typhimurium were chosen as appropriate candidates for their incorporation in order to create polyvalent Salmonella ``ghost`` vaccine for veterinary use.
dc.identifier.doi10.1155/2015/101464
dc.identifier.issn1687-4129
dc.identifier.issn1687-4110
dc.identifier.scopusSCOPUS_ID:84938675541en
dc.identifier.urihttps://rlib.uctm.edu/handle/123456789/342
dc.language.isoen
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84938675541&origin=inward
dc.titleExperimental Study on the Components in Polyvalent ``ghost`` Salmonella Vaccine for Veterinary Use
dc.typeArticle
oaire.citation.volume2015
Files
Collections
Articles